As of 2022, in nearly every country in Europe, over half of adults were classed as overweight or obese. The highest rate was recorded in Romania with 67 percent of adults self-reporting as overweight or obese. In both Croatia and the United Kingdom, around 64 percent of adults had a BMI of over 25. Europe one of the worst affected regions Europe had the second-highest number of obese adults across the WHO regions, only behind the region of the Americas. Over 191 million adults aged 20 years were classed as obese in Europe in 2020. The number of obese adults in Europe was forecast to grow to 263 million by 2035. Problems also with childhood obesity In 2020, 89 million children in Europe were overweight, the highest across all continents. It was forecast with current trends that, by 2035, 125 million children would be overweight. A further 70 million children across the continent were classed as obese. Children that are overweight or obese are at a higher risk of developing numerous health conditions, such as type 2 diabetes, asthma, and high blood pressure.

By 2025, the prevalence of obese women in the United Kingdom is projected to be at 36 percent, this would be the highest obesity prevalence in women compared to EU countries. Ireland with 33.4 percent was forecast to have the second highest prevalence of obese women in Europe, followed by Malta at 32 percent.

As of 2021, approximately 69 percent of men and 59 percent of women in the United Kingdom considered themselves overweight or obese. Across the European countries featured, overweight and obesity was more prevalent among males.

By 2030, Hungary, Turkey, and Croatia were projected to have the highest prevalence of childhood obesity (between 5 and 19 years of age) across Europe at 19 percent. Across the whole of Europe, it was projected that just over 16 percent of children aged between five and nine years of age would be classed as obese by 2030.

By 2030, Malta, Hungary, and the United Kingdom were projected to have the highest prevalence of obesity in their populations among men in Europe. Across the whole of Europe, approximately 30 percent of men were forecast to be classified as obese in 2030.

By 2025, the prevalence of obese children in Greece is projected to reach 16.7 percent, this would be the highest childhood obesity prevalence across all countries in the EU and the UK. Hungary with 16.2 percent was forecast to have the second highest prevalence of childhood obesity in Europe, followed by Croatia at 15.9 percent.

By 2025, the prevalence of obese men in Hungary was projected to be at 36 percent, this would be the highest obesity prevalence in men across all countries in the EU and the United Kingdom. Malta with 35.9 percent was forecast to have the second highest prevalence of obese men in Europe, followed by the United Kingdom at 35.4 percent.

This statistic displays the obesity prevalence in selected European countries by 2025. Great Britain is set to be the most obese nation in Europe by 2025 with an obesity prevalence of 37.7 percent, followed closely by Ireland and Lithuania with an expected prevalence rate of 37.65 percent respectively.

The size of the Weight Loss Surgery Market in Europe market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 15.00% during the forecast period. Bariatric surgery is more commonly known as weight loss surgery, and for the time being it has emerged as a realistic solution for serious problems associated with obese individuals in Europe. Bariatric surgery is a procedure that involves modification of the digestive system for the purposes of reduced food intake and absorption, hence causing subsequent weight loss. There is the provision of the procedure for people whose BMI goes over 40 years and those with a BMI of 35 or more and who suffer from severe medical conditions. This includes type two diabetes, sleep apnea, or severe heart disease. The weight loss surgery market in Europe is highly booming due to several factors. The growing rates of obesity in the continent and health consequences caused by it increased the demand for effective management of weight. With the developments and improvements created in the sphere of surgical procedures and also care after surgery, bariatric operations have not only become less dangerous but also more efficient. In addition to the above, a good quality of life, diminution of chronic diseases, and an increased lifespan, which are part of the bariatric surgery benefits, support the growth of the market. A majority of European countries have come forward to the forefront in the weight loss surgery market. Germany boasts the world-class health care system and surgical experience; hence, it is the destination preferred for bariatric surgeries. Solid bariatric surgery programs exist in the United Kingdom, France, and Sweden, that attract patients from domestic and international markets. There are several advantages of weight loss surgery; however, it must be remembered that it is not a magic solution for losing weight. Commitment to a lifestyle change, which embodies alteration in diet and exercise, can be an arduous task for patients who have to carry it long after the surgery. This surgical procedure is not without its risks and complications-infection, for instance, to possible internal bleeding and nutrient deficiencies. All of these being considered, therefore, great care and more so consultation with a qualified health professional are paramount before one makes a decision on this approach to weight loss surgery. Recent developments include: In June 2022, Rhythm Pharmaceuticals, Inc. announced that IMCIVREE is available to patients in Germany.The European Commission granted IMCIVREE marketing authorization for the treatment of obesity and the management of hunger in adults and children aged 6 and older with genetically confirmed loss-of-function biallelic pro-opiomelanocortin, including proprotein convertase subtilisin/kexin type 1 deficiency or biallelic leptin receptor deficiency., In June 2022, European Medicines Agency (EMA) safety committee Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the withdrawal of European Union (EU) marketing authorisations for amfepramone obesity medicines.. Key drivers for this market are: Increase in Obese Population, Prevalence of Diabetes and Heart Diseases; Government Initiatives to Curb Obesity; Insurance Coverage of Surgeries. Potential restraints include: Lack of Knowledge and Awareness in the Region, High Cost of Surgery. Notable trends are: Gastric Balloons Segment is Expected to Witness the Highest CAGR in the Market Over the Forecast Period.

By 2030, Turkey was projected to have the highest prevalence of obesity among women at 50 percent, followed by the United Kingdom at 37 percent. Across the whole of Europe, almost 30 percent of women were forecast to have a BMI classified as obese by 2030.

IntroductionOvereating is one of the main drivers of obesity due to the accumulation of excess body fat (EBF). This issue not only impacts human health but also depletes the planet’s environmental resources through the production of excess food. Thus, the Metabolic Food Waste (MFW) index was developed to measure the food wasted due to EBF accumulation, associated greenhouse gas (GHG) emissions, and the water and land resources used in its production.MethodsThe present study aims to evaluate and compare the MFW and ecological footprints of some Mediterranean countries (MC) and North European countries (NEC). The MFW for six Mediterranean and North European countries (NEC) was calculated using the following: (i) EBF: This is defined as the difference between ideal and actual body weight in overweight and obese adults, with data sourced from the FAOSTAT and WHO databases; (ii) Food waste: This includes the food wasted due to EBF accumulation and energy intake from major food categories. Data for food waste were obtained from the FAO Food Balance Sheets; and (iii) Environmental Impact: This encompasses GHG emissions, water consumption, and land use associated with EBF by different foods. Data were obtained from the WWF Virtual Shopping Cart and the Barilla Centre for Food and Nutrition. Data were analyzed for the total population and standardized per 100,000 citizens.ResultsThe results showed that NEC had the highest rates of obesity, while MC recorded slightly higher rates of individuals classified as overweight. Overall, higher EBF values for 100,000 citizens, including both obese and overweight individuals, were found in NEC compared to MC, with smaller population countries predominantly contributing to these trends. Data on MFW and ecological footprints showed that, regardless of the country, the impact of obesity is two to three times greater than that of being overweight. The highest values of MFW and ecological footprints were found in MC, both in the total and among overweight/obese populations.DiscussionThe present study highlights the harmful role of the overeating as on human health as on the resource exploitations of the Earth. In particular, both MC and NEC showed similar alarming data about overeating and, consequently, negative impact on EBF and ecological footprints, suggesting that residence in countries close or far from Mediterranean basin is not a proxy of adherence to healthy dietary patterns. For this reason, informative campaigns should be developed to improve the knowledge on conscious dietary choices for human and planet healthiness.

Background: In Europe, although the prevalence of childhood obesity seems to be plateauing in some countries, progress on tackling this important public health issue remains slow and inconsistent. Breastfeeding has been described as a protective factor, and the more exclusively and the longer children are breastfed, the greater their protection from obesity. Birth weight has been shown to have a positive association with later risk for obesity. Objectives: It was the aim of this paper to investigate the association of early-life factors, namely breastfeeding, exclusive breastfeeding and birth weight, with obesity among children. Method: Data from 22 participating countries in the WHO European COSI study (round 4: 2015/2017) were collected using cross-sectional, nationally representative samples of 6- to 9-year-olds (n = 100,583). The children’s standardized weight and height measurements followed a common WHO protocol. Information on the children’s birth weight and breastfeeding practice and duration was collected through a family record form. A multivariate multilevel logistic regression analysis regarding breastfeeding practice (both general and exclusive) and characteristics at birth was performed. Results: The highest prevalence rates of obesity were observed in Spain (17.7%), Malta (17.2%) and Italy (16.8%). A wide between-country disparity in breastfeeding prevalence was found. Tajikistan had the highest percentage of children that were breastfed for ≥6 months (94.4%) and exclusively breastfed for ≥6 months (73.3%). In France, Ireland and Malta, only around 1 in 4 children was breastfed for ≥6 months. Italy and Malta showed the highest prevalence of obesity among children who have never been breastfed (21.2%), followed by Spain (21.0%). The pooled analysis showed that, compared to children who were breastfed for at least 6 months, the odds of being obese were higher among children never breastfed or breastfed for a shorter period, both in case of general (adjusted odds ratio [adjOR] [95% CI] 1.22 [1.16–1.28] and 1.12 [1.07–1.16], respectively) and exclusive breastfeeding (adjOR [95% CI] 1.25 [1.17–1.36] and 1.05 [0.99–1.12], respectively). Higher birth weight was associated with a higher risk of being overweight, which was reported in 11 out of the 22 countries. Bulgaria, Croatia, France, Italy, Poland and Romania showed that children who were preterm at birth had higher odds of being obese, compared to children who were full-term babies. Conclusion: The present work confirms the beneficial effect of breastfeeding against obesity, which was highly increased if children had never been breastfed or had been breastfed for a shorter period. Nevertheless, adoption of exclusive breastfeeding is below global recommendations and far from the target endorsed by the WHO Member States at the World Health Assembly Global Targets for Nutrition of increasing the prevalence of exclusive breastfeeding in the first 6 months up to at least 50% by 2025.

Obese Patient Care System Market Outlook

The global market size for Obese Patient Care Systems was estimated to be around USD 3.2 billion in 2023, with a Compound Annual Growth Rate (CAGR) of approximately 7.5% expected to drive the market to an estimated USD 6.4 billion by 2032. One of the key growth factors for this market includes the rising prevalence of obesity worldwide, which necessitates specialized equipment and systems to manage the unique healthcare needs of obese patients.

One of the primary growth factors for the obese patient care system market is the increasing prevalence of obesity globally. According to the World Health Organization (WHO), the number of obese individuals has tripled since 1975. As obesity is associated with various comorbidities such as diabetes, cardiovascular diseases, and musculoskeletal disorders, the need for specialized healthcare systems to cater to this demographic has become imperative. This trend is creating a sustained demand for obese patient care systems, ranging from beds and wheelchairs to specialized scales and lifts.

Technological advancements are another significant growth factor contributing to the expansion of the obese patient care system market. Innovations in medical devices, such as advanced bariatric beds with integrated monitoring systems and automated wheelchairs, are enhancing patient comfort and care efficiency. Manufacturers are increasingly focusing on developing user-friendly, durable, and multifunctional equipment that can withstand higher weights while ensuring safety. These technological improvements are making it easier for healthcare providers to deliver optimal care to obese patients, thereby driving market growth.

Government initiatives and policies aimed at combating obesity and improving healthcare infrastructure are also playing a crucial role in market expansion. Various countries are investing in healthcare facilities and programs to manage obesity more effectively. These initiatives often include funding for specialized equipment and training for healthcare providers, which in turn bolsters the demand for obese patient care systems. For instance, government grants and subsidies for hospitals to purchase bariatric equipment can significantly impact market growth.

In terms of regional outlook, North America is expected to dominate the obese patient care system market, followed by Europe and the Asia Pacific. The high prevalence of obesity in North America, particularly in the United States, along with well-established healthcare infrastructure, contributes to this dominance. Europe also shows significant potential due to rising obesity rates and increased healthcare spending. The Asia Pacific region, with its growing healthcare infrastructure and increasing awareness about obesity management, is anticipated to witness the highest growth rate during the forecast period.

Product Type Analysis

The product type segment of the obese patient care system market includes beds, lifts, scales, wheelchairs, commodes, and others. Each of these product types serves a unique role in managing and providing care for obese patients, making them indispensable in various healthcare settings. Among these, bariatric beds are one of the most crucial components, designed to accommodate higher weight capacities while providing comfort and safety. These beds often come with advanced features such as electric adjustments, integrated scales, and specialized mattresses to prevent pressure sores, making them highly sought after in hospitals and home care settings.

Lifts are another essential product type within the obese patient care system market. These devices are designed to assist in the safe and efficient transfer of obese patients, thereby reducing the risk of injury to both patients and healthcare providers. Modern lifts often come with advanced features like motorized operation, remote control, and multi-functional slings, enhancing their usability and effectiveness. The increasing focus on patient safety and comfort is driving the demand for advanced lift systems.

Scales specifically designed for obese patients are crucial for monitoring weight and managing overall health. These scales often have higher weight capacities and larger platforms compared to standard scales, ensuring accurate measurements for obese individuals. Some advanced models also offer digital readouts, wireless connectivity, and integration with electronic health records (EHR) systems, enhancing their utility in clinical settings. The growing emphasis on monitoring and managing obesity-related hea

European Cream (Fat Content >29%) Production Share by Country (Thousand Metric Tons), 2023 Discover more data with ReportLinker!

The European weight loss surgery market is experiencing robust growth, driven by rising obesity rates, increasing awareness of bariatric procedures, and advancements in minimally invasive surgical techniques. The market, valued at approximately €X million in 2025 (assuming a logical extrapolation based on the provided CAGR of 15% and the unspecified market size "XX" – a precise figure requires the missing "XX" value), is projected to reach €Y million by 2033. This significant expansion is fueled by several key factors. The increasing prevalence of obesity and related comorbidities like type 2 diabetes and cardiovascular disease is creating a substantial demand for effective weight loss solutions. Furthermore, technological advancements in devices such as suturing devices, stapling devices, and implantable gastric bands are leading to safer, less invasive procedures with improved patient outcomes, driving market penetration. The segment of assisting devices, encompassing suturing, closure, and stapling devices, is expected to dominate the market due to its widespread use in various bariatric surgeries. However, the growth is also influenced by factors like high procedure costs, potential complications associated with surgery, and varying reimbursement policies across European countries. Growth across the major European markets – Germany, the United Kingdom, France, Italy, and Spain – will contribute significantly to the overall market expansion. However, disparities in healthcare infrastructure and insurance coverage may lead to regional variations in adoption rates. The competitive landscape includes established players like Allergan, Ethicon, and Covidien, as well as emerging companies focusing on innovative technologies. These companies are constantly investing in research and development to introduce advanced devices and improve surgical techniques, further propelling the market's growth. While regulatory hurdles and potential risks associated with weight loss surgery present challenges, the overall outlook for the European weight loss surgery market remains positive, indicating substantial growth opportunities over the forecast period. (Note: 'X' and 'Y' represent calculated values derived from the 15% CAGR and the missing base market size. To obtain precise figures, the missing market size data is required). Recent developments include: In June 2022, Rhythm Pharmaceuticals, Inc. announced that IMCIVREE is available to patients in Germany.The European Commission granted IMCIVREE marketing authorization for the treatment of obesity and the management of hunger in adults and children aged 6 and older with genetically confirmed loss-of-function biallelic pro-opiomelanocortin, including proprotein convertase subtilisin/kexin type 1 deficiency or biallelic leptin receptor deficiency., In June 2022, European Medicines Agency (EMA) safety committee Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the withdrawal of European Union (EU) marketing authorisations for amfepramone obesity medicines.. Key drivers for this market are: Increase in Obese Population, Prevalence of Diabetes and Heart Diseases; Government Initiatives to Curb Obesity; Insurance Coverage of Surgeries. Potential restraints include: Increase in Obese Population, Prevalence of Diabetes and Heart Diseases; Government Initiatives to Curb Obesity; Insurance Coverage of Surgeries. Notable trends are: Gastric Balloons Segment is Expected to Witness the Highest CAGR in the Market Over the Forecast Period.

European Export of Butter and Fats Derived from Milk of a Fat Content by Weight Exceeding 85% Share by Country (Kilograms), 2023 Discover more data with ReportLinker!

European Margarine and Low Fat Spreads Market Size Value Per Capita by Country, 2023 Discover more data with ReportLinker!

Bariatric Lift Market Outlook

The global bariatric lift market size was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2032. The growth factor for this remarkable increase is primarily attributed to the rising prevalence of obesity and related health complications, which necessitate the use of bariatric lifts in various healthcare settings.

One of the most significant drivers of the bariatric lift market is the increasing rate of obesity across the globe. According to the World Health Organization (WHO), obesity has nearly tripled since 1975, and in 2016, more than 1.9 billion adults were overweight, with over 650 million of them classified as obese. This alarming trend has led to a surge in demand for bariatric lifts, as these devices are crucial for the safe and effective handling of obese patients, particularly in hospital and home care settings. The increasing investment in healthcare infrastructure and the rising awareness about the importance of safe patient handling are also contributing to market growth.

Technological advancements in bariatric lift systems are another key growth factor. Manufacturers are continuously innovating and developing advanced lifts that offer enhanced safety, comfort, and ease of use for both patients and caregivers. Features such as remote controls, battery-powered operations, and ergonomic designs are becoming increasingly popular. Additionally, the integration of smart technologies, such as IoT and AI, into bariatric lifts is expected to further drive market growth by providing real-time monitoring and data analytics capabilities, which can significantly improve patient outcomes and reduce caregiver injuries.

The increasing geriatric population is another demographic factor fueling the growth of the bariatric lift market. Older adults are more likely to suffer from mobility issues and obesity-related complications, necessitating the use of bariatric lifts for safe patient transfers and mobility assistance. As the global population continues to age, with the United Nations projecting that one in six people in the world will be over the age of 65 by 2050, the demand for bariatric lifts is expected to rise substantially.

Regionally, North America dominates the bariatric lift market, driven by the high prevalence of obesity, advanced healthcare infrastructure, and significant government and private sector investments in healthcare. The United States, in particular, is a major contributor to market growth, owing to its large obese population and the growing adoption of advanced medical devices. Europe follows closely, with countries like Germany, the UK, and France exhibiting strong demand for bariatric lifts due to their well-established healthcare systems and increasing focus on patient safety. The Asia Pacific region is also expected to witness significant growth, driven by rising healthcare expenditure, increasing awareness about obesity-related health issues, and the growing adoption of advanced medical technologies.

In the context of the growing bariatric lift market, the Bariatric Lift Chair has emerged as a vital component for enhancing patient comfort and care. These chairs are specifically designed to accommodate individuals with obesity, providing them with a safe and comfortable seating option that supports their weight and mobility needs. The Bariatric Lift Chair not only aids in reducing the physical strain on caregivers during patient transfers but also promotes independence for patients by allowing them to adjust their seating position with ease. As healthcare facilities increasingly prioritize patient-centered care, the demand for such specialized equipment is expected to rise, further driving the growth of the bariatric lift market.

Product Type Analysis

The bariatric lift market is segmented into three main product types: electric bariatric lifts, hydraulic bariatric lifts, and manual bariatric lifts. Electric bariatric lifts are expected to dominate the market due to their ease of use, advanced features, and growing preference among healthcare providers. These lifts are powered by electric motors and often come with remote controls, making them highly convenient for both patients and caregivers. The demand for electric bariatric lifts is pa

Weight Loss Market Outlook

The global weight loss market is poised for significant growth, with a projected market size of USD 254 billion in 2023 and expected to reach USD 402 billion by 2032, reflecting a robust CAGR of 5.1% during the forecast period. This growth is largely fueled by an increasing awareness of health and wellness, rising obesity rates, and the growing adoption of fitness regimes across various demographics. As lifestyles shift towards more sedentary habits combined with the increasing prevalence of unhealthy eating habits, the focus on weight management has become more pronounced, leading to a surge in demand for weight loss products and services.

Several growth factors drive this market, with one of the primary catalysts being the global rise in obesity rates, which have reached epidemic proportions in many parts of the world. The World Health Organization has identified obesity as a significant public health challenge, prompting governments and health organizations to advocate for healthier lifestyles. This has resulted in increased funding and initiatives aimed at promoting fitness and nutrition education. Additionally, the proliferation of digital platforms and social media has raised awareness about fitness and well-being, encouraging individuals to invest in weight loss solutions. This shift is further bolstered by the availability of personalized and technology-driven weight management solutions that cater to individual needs and preferences.

The increasing disposable income in developing countries is also contributing to market growth. As economies improve, consumers have more to spend on health and wellness products, including dietary supplements and fitness equipment. This trend is particularly evident in the Asia Pacific and Latin America regions, where economic development has been rapid. Furthermore, the aging population in developed nations like North America and Europe is seeking healthier lifestyles to maintain their quality of life, thereby contributing to the demand for weight loss products and services. The wellness trend, characterized by a holistic approach to health that encompasses physical, mental, and emotional well-being, is also driving the market forward.

Another significant factor propelling market growth is the innovation and diversification of weight loss products and services. Manufacturers and service providers are consistently developing new and improved products to meet the evolving needs of consumers. This includes the introduction of plant-based dietary supplements, gluten-free meal replacements, and technologically advanced fitness equipment. The industry is also witnessing a surge in demand for convenient and effective home-based fitness solutions, fueled by the COVID-19 pandemic and subsequent lockdowns that led to the closure of fitness centers and increased the popularity of home workouts.

The Fat Burner Supplement Sales have seen a remarkable increase as consumers seek effective solutions to enhance their weight loss efforts. These supplements, often formulated with ingredients like caffeine, green tea extract, and L-carnitine, are designed to boost metabolism and promote fat oxidation. The growing interest in these products is driven by their perceived benefits in accelerating weight loss results when combined with a balanced diet and regular exercise. As the market for dietary supplements expands, manufacturers are focusing on transparency and scientific validation to build consumer trust. This trend aligns with the broader movement towards personalized nutrition, where individuals seek tailored solutions to meet their specific health and fitness goals.

Regionally, North America is expected to hold a significant share of the weight loss market, driven by high obesity rates and a well-established fitness culture. Europe follows closely, with a strong emphasis on health and wellness and a growing trend towards organic and natural weight loss solutions. The Asia Pacific region is anticipated to experience the fastest growth due to rising health consciousness and an expanding middle class. Latin America and the Middle East & Africa also present growth opportunities, albeit at a slower pace, as awareness and access to weight loss products and services increase.

Product Type Analysis

The weight loss market is segmented into several product types, including dietary supplements, meal replacements, fitness equipment, and others. Dietary supplements are a significant contrib

General practitioners (GPs) form the gateway to healthcare in numerous European countries. Their role in addressing and managing overweight/obesity in children is crucial. In Dutch guidelines, GPs are encouraged to proactively address weight-related issues during patient consultations, regardless of the initial reason of the visit. To examine the frequency, management and follow-up of GP visits of children for overweight/obesity and the identification by GPs of these children presenting with other complaints. A retrospective cohort study. Health records from 2012–2021 in the Rijnmond Primary Care Database (RPCD) of children aged 2–18 with overweight/obesity who visited the GP were analysed. Children were categorised into two groups: those visiting for weight-related issues (group 1) and those visiting for other complaints but identified as overweight or obese by GPs (group 2). Data on patient demographics, reasons for contact, and management strategies were extracted. From the 120,991 children, 3035 children with documented overweight or obesity were identified, 208 were excluded. The study population comprised 2827 individuals: 55% belonging to group 1, 45% to group 2. The frequency of first visits remained stable at approximately 0.5% visits per total person-years each year. Group 1 received more referrals (74%) and follow-up consultations (45.5%) than group 2 with 17% referrals and 19.7% follow-up consultations. This study highlights a concerning difference in the management of the two groups. Strategies for effective management of overweight in children and the GP’s role, warrant further investigation. Especially when overweight is not the primary reason for visit. Children rarely visit general practitioners for weight-related issues. GPs recognise children with overweight but document and refer them less frequently than children who visit the GP for a weight-related issue. Addressing overweight/obesity at the point of visit is an opportunity to improve weight control in children.